CNLAC1 Is Required for Extrapulmonary Dissemination of Cryptococcus neoformans but Not Pulmonary Persistence

Infection and Immunity

Volumn 72, Issue 3, 2004, Pages 1693-1699

  Noverr, Mairi C ^a   Williamson, Peter R ^b   Fajardo, Ryan S ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACCASE; MONOPHENOL MONOOXYGENASE; PHENOL DERIVATIVE; VIRULENCE FACTOR;

ARTICLE; BRAIN; CATALYSIS; CELLULAR IMMUNITY; CNLAC1 GENE; CRYPTOCOCCUS NEOFORMANS; ENZYME REGULATION; FUNGAL VIRULENCE; FUNGUS GROWTH; GENE; GENE MUTATION; MELANOGENESIS; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPLEEN;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENES, FUNGAL; IMMUNITY, CELLULAR; LACCASE; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED CBA; MUTATION; VIRULENCE;

EID: 1342344911     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.3.1693-1699.2004     Document Type: Article

References (43)

1. Alspaugh, J. A., J. R. Perfect, and J. Heitman. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 11:3206-3217.
2. Barluzzi, R., A. Brozzetti, G. Mariucci, M. Tantucci, R. G. Neglia, F. Bistoni, and E. Blasi. 2000. Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, nonmelanogenic Cryptococcus neoformans strain. J. Neuroimmunol. 109:75-86.
3. Blasi, E., R. Barluzzi, R. Mazzolla, B. Tancini, S. Saleppico, M. Puliti, L. Pitzurra, and F. Bistoni. 1995. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58:111-116.
4. Cauley, L. K., and J. W. Murphy. 1979. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun. 23:644-651.
5. Chang, Y. C., and K. J. Kwon-Chung. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
6. Chang, Y. C., B. L. Wickes, G. F. Miller, L. A. Penoyer, and K. J. Kwon-Chung. 2000. Crypotococcus neoformans STE12alpha regulates virulence but is not essential for mating. J. Exp. Med. 191:871-882.
7. Chen, S. C., M. Muller, J. Z. Zhou, L. C. Wright, and T. C. Sorrell. 1997. Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J. Infect. Dis. 175:414-420.
8. Cox, G. M., H. C. McDade, S. C. Chen, S. C. Tucker, M. Gottfredsson, L. C. Wright, T. C. Sorrell, S. D. Leidich, A. Casadevall, M. A. Ghannoum, and J. R. Perfect. 2001. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39:166-175.
9. Cox, G. M., J. Mukherjee, G. T. Cole, A. Casadevall, and J. Perfect. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:443-438.
10. Doering, T. L., J. D. Nosanchuk, W. K. Roberts, and A. Casadevall. 1999. Melanin as a potential cryptococcal defense against mcirobicidal proteins. Med. Mycol. 37:175-181.
11. Huffnagle, G. B., G.-H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507.
12. Jacobson, E., and S. Tinnell. 1993. Antioxidant function of fungal melanin. J. Bacteriol. 175:7102-7104.
13. Jacobson, E. S., and H. S. Emery. 1991. Temperature regulation of the cryptococcal phenoloxidase. J. Med. Vet. Mycol. 29:121-124.
14. Kwon-Chung, K. J., and J. E. Bennett. 1984. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentbl. Bakteriol. Hyg. A 257:213-218.
15. Kwon-Chung, K. J., I. Polacheck, and T. J. Popkin. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J. Bacteriol. 150:1414-1421.
16. Lee, S. C., Y. Kress, D. W. Dickson, and A. Casadevall. 1995. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody. J. Neuroimmunol. 62:43-52.
17. Levy, R. M., D. E. Bredesen, and M. L. Rosenblum. 1985. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J. Neurosurg. 62:475-495.
18. Liu, L., R. Tweari, and P. R. Williamson. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
19. Liu, L., K. Wakamatsu, S. Ito, and P. R. Williamson. 1999. Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice. Infect. Immun. 67:108-112.
20. Luberto, C., B. Martínez-Marino, D. Taraskiewicz, B. Bolanos, P. Chitano, D. L. Toffaletti, G. M. Cox, J. R. Perfect, Y. A. Hannun, E. Balish, and M. D. Poeta. 2003. Identification of Appl as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Investig. 112:1080-1094.
21. Luberto, C., D. L. Toffaletti, E. A. Wills, S. C. Tucker, A. Casadevall, J. R. Perfect, Y. A. Hannun, and M. M. Del Poeta. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of Cryptococcus neoformans. Genes Dev. 15:201-212.
22. Mitchell, T. G., and L. Friedman. 1972. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5:491-498.
23. Nosanchuk, J. D., A. L. Rosas, S. C. Lee, and A. Casadevall. 2000. Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355:2049-2050.
24. Noverr, M. C., G. M. Cox, J. R. Perfect, and G. B. Huffnagle. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71:1538-1547.
25. Olszewski, M. A., M. C. Noverr, G. H. Chen, G. B. Toews, G. M. Cox, J. R. Perfect, and G. B. Huffnagle. Urease promotes Cryptococcus neoformans neurotropism by enhancing microcapillary sequestration. Am. J. Pathol., in press.
26. Perfect, J. R., and A. Casadevall. 2002. Cryptococcosis. Infect. Dis. Clin. N. Am. 16:837-874.
27. Polacheck, I., Y. Platt, and J. Aronovitch. 1990. Catecholamines and virulence of Cryptococcus neoformans. Infect. Immun. 58:2919-2122.
28. Randhawa, H. S., A. Y. Mussa, and Z. U. Khan. 2001. Decaying wood in tree trunk hollows as a natural substrate for Cryptococcus neoformans and other yeast-like fungi of clinical interest. Mycopathologia 151:63-69.
29. Randhawa, H. S., and D. K. Paliwal. 1977. Occurrence and significance of Cryptococcus neoformans in the oropharynx and on the skin of a healthy human population. J. Clin. Microbiol. 6:325-327.
30. Randhawa, H. S., and D. K. Paliwal. 1979. Survey of Cryptococcus neoformans in the respiratory tract of patients with bronchopulmonary disorders and in the air. Sabouraudia 17:399-404.
31. Reblin, T., A. Meyer, H. Albrecht, and H. Greten. 1994. Disseminated cryptococcosis in a patient with AIDS. Mycoses 37:275-279.
32. Rhodes, J., I. Polacheck, and K. Kwon-Chung. 1982. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect. Immun. 36:1175-1184.
33. Ruiz, A., D. Velez, and R. A. Fromtling. 1989. Isolation of saprophytic Cryptococcus neoformans from Puerto Rico: distribution and variety. Mycopathologia 106:167-170.
34. Salas, S. D., J. E. Bennett, K. J. Kwon-Chung, and J. Perfect. 1996. Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:377-386.
35. Sampaio, R. N., B. Medeiros, M. Milfort, G. F. Alves, C. M. Reis, and I. T. Campbell. 1999. Systemic cryptococcosis with solitary cutaneous lesion in an immunocompetent patient. Int. J. Dermatol. 38:773-775.
36. Vecchiarelli, A., C. Retini, D. Pietrella, C. Monari, and T. R. Kozel. 2000. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro. Eur. J. Immunol. 30:1385-1393.
37. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
38. Wang, Y., and A. Casadevall. 1994. Growth of Cryptococcus neoformans in the presence of L-dopa decreases its susceptibility to amphoteracin B. Antimicrob. Agents Chemother. 38:2648-2650.
39. Wilder, J. A., G. K. Olson, Y. C. Chang, K. J. Kwon-Chung, and M. F. Lipscomb. 2002. Complementation of a capsule-deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection. Am. J. Respir. Cell. Mol. Biol. 26:306-314.
40. Williamson, P. R. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:656-664.
41. Yang, Z., R. C. Pascon, A. Alspaugh, G. M. Cox, and J. H. McCusker. 2002. Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology 148:2617-2625.
42. Yasuoka, A., S. Kohno, H. Yamada, M. Kaku, and H. Koga. 1994. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis. Microbiol. Immunol. 38:851-856.
43. Zhu, X., J. Gibbons, J. García-Rivera, A. Casadevall, and P. R. Williamson. 2001. Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect. Immun. 69:5589-5596.